A

Accel-Rx - Canada's Health Science Accelerator

3 employees

Accel-Rx is a business accelerator focused on companies based in the health sciences sector.

Investor insights

Sectors invested in

Biotechnology8
Health Care7
Pharmaceutical5
Medical3
Biopharma2
Medical Device2
Therapeutics2
bone1
Noninvasive patient monitoring1
Critical Care Medicine1
Fluid Management1
Hemodynamic monitoring1
Diabetes1
Clinical Trials1
Genetics1
Manufacturing1
Hematology1
Cellular Therapy1
Oncology1
hypoglycemia1

Funding rounds participated in

$3.5M sweet spot round size

Most of their 14 investments are in rounds between $1.8M and $5M

Investor type

Accelerator

Basic info

Industry

pharmaceuticals

Date founded

2014

Investments made

I

Inversago Pharma Inc raised $7M on July 25, 2018

Investors: Anges Québec, Tarnagulla Ventures, JDRF T1D Fund, Genesys Capital, AQC Capital and Accel-Rx - Canada's Health Science Accelerator

F

Flosonics Medical raised $5M on January 29, 2018

Investors: Genesys Capital, Angel One Investor Network, iGan Partners, Amplify Capital (formerly MaRS Catalyst Fund), MaRS Investment Accelerator Fund and Accel-Rx - Canada's Health Science Accelerator

U

Undisclosed raised undisclosed on January 1, 2018

Investors: Accel-Rx - Canada's Health Science Accelerator

M

Mesentech raised undisclosed on January 1, 2018

Investors: Accel-Rx - Canada's Health Science Accelerator

U

Undisclosed raised undisclosed on November 27, 2017

Investors: Anges Québec, AQC Capital, Lumira Ventures and Accel-Rx - Canada's Health Science Accelerator

S

SpecificiT Pharma Inc. raised undisclosed on September 11, 2017

Investors: Sanderling Ventures and Accel-Rx - Canada's Health Science Accelerator

Z

Zucara Therapeutics Inc. raised $525K on November 3, 2016

Investors: Accel-Rx - Canada's Health Science Accelerator

S

Soundbite Medical Solutions Inc. raised $5M on October 31, 2016

Investors: Accel-Rx - Canada's Health Science Accelerator

U

Undisclosed raised undisclosed on October 12, 2016

Investors: Lumira Ventures, CCRM and Accel-Rx - Canada's Health Science Accelerator

I

ImStar Therapeutics Inc. raised $1.8M on June 8, 2016

Investors: Accel-Rx - Canada's Health Science Accelerator

FAQ